United States Neuromodulation Market Report 2016

United States Neuromodulation Market Report 2016

1 Neuromodulation Overview

1.1 Product Overview and Scope of Neuromodulation

1.2 Classification of Neuromodulation

1.2.1 Internal Neuromodulation

1.2.2 External Neuromodulation

1.2.3 Type III

1.3 Application of Neuromodulation

1.3.1 Spinal Cord Stimulation

1.3.2 Deep Brain Stimulation

1.3.3 Sacral Nerve Stimulation

1.3.4 Vagus Nerve Stimulation Market

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Neuromodulation (2011-2021)

1.4.1 United States Neuromodulation Sales and Growth Rate (2011-2021)

1.4.2 United States Neuromodulation Revenue and Growth Rate (2011-2021)

2 United States Neuromodulation Competition by Manufacturers

2.1 United States Neuromodulation Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Neuromodulation Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Neuromodulation Average Price by Manufactures (2015 and 2016)

2.4 Neuromodulation Market Competitive Situation and Trends

2.4.1 Neuromodulation Market Concentration Rate

2.4.2 Neuromodulation Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Neuromodulation Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Neuromodulation Sales and Market Share by Type (2011-2016)

3.2 United States Neuromodulation Revenue and Market Share by Type (2011-2016)

3.3 United States Neuromodulation Price by Type (2011-2016)

3.4 United States Neuromodulation Sales Growth Rate by Type (2011-2016)

4 United States Neuromodulation Sales (Volume) by Application (2011-2016)

4.1 United States Neuromodulation Sales and Market Share by Application (2011-2016)

4.2 United States Neuromodulation Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Neuromodulation Manufacturers Profiles/Analysis

5.1 Medtronic, Inc. (U.S.)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Neuromodulation Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Medtronic, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Boston Scientific Corporation (U.S.)

5.2.2 Neuromodulation Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Boston Scientific Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 St. Jude Medical, Inc. (U.S.)

5.3.2 Neuromodulation Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 St. Jude Medical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Synapse Biomedical, Inc. (U.S.)

5.4.2 Neuromodulation Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Synapse Biomedical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Nevro Corporation (U.S.)

5.5.2 Neuromodulation Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Nevro Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Neurosigma, Inc. (U.S.)

5.6.2 Neuromodulation Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Neurosigma, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Neuropace, Inc. (U.S.).

5.7.2 Neuromodulation Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Neuropace, Inc. (U.S.). Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Neuronetics, Inc. (U.S.)

5.8.2 Neuromodulation Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Neuronetics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Cyberonics, Inc. (U.S.)

5.9.2 Neuromodulation Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Cyberonics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 BioControl Medical (Israel)

5.10.2 Neuromodulation Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 BioControl Medical (Israel) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Neuromodulation Manufacturing Cost Analysis

6.1 Neuromodulation Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Neuromodulation

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Neuromodulation Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Neuromodulation Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Neuromodulation Market Forecast (2016-2021)

10.1 United States Neuromodulation Sales, Revenue Forecast (2016-2021)

10.2 United States Neuromodulation Sales Forecast by Type (2016-2021)

10.3 United States Neuromodulation Sales Forecast by Application (2016-2021)

10.4 Neuromodulation Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Neuromodulation

Table Classification of Neuromodulation

Figure United States Sales Market Share of Neuromodulation by Type in 2015

Figure Internal Neuromodulation Picture

Figure External Neuromodulation Picture

Table Application of Neuromodulation

Figure United States Sales Market Share of Neuromodulation by Application in 2015

Figure Spinal Cord Stimulation Examples

Figure Deep Brain Stimulation Examples

Figure Sacral Nerve Stimulation Examples

Figure Vagus Nerve Stimulation Market Examples

Figure United States Neuromodulation Sales and Growth Rate (2011-2021)

Figure United States Neuromodulation Revenue and Growth Rate (2011-2021)

Table United States Neuromodulation Sales of Key Manufacturers (2015 and 2016)

Table United States Neuromodulation Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Neuromodulation Sales Share by Manufacturers

Figure 2016 Neuromodulation Sales Share by Manufacturers

Table United States Neuromodulation Revenue by Manufacturers (2015 and 2016)

Table United States Neuromodulation Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Neuromodulation Revenue Share by Manufacturers

Table 2016 United States Neuromodulation Revenue Share by Manufacturers

Table United States Market Neuromodulation Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Neuromodulation Average Price of Key Manufacturers in 2015

Figure Neuromodulation Market Share of Top 3 Manufacturers

Figure Neuromodulation Market Share of Top 5 Manufacturers

Table United States Neuromodulation Sales by Type (2011-2016)

Table United States Neuromodulation Sales Share by Type (2011-2016)

Figure United States Neuromodulation Sales Market Share by Type in 2015

Table United States Neuromodulation Revenue and Market Share by Type (2011-2016)

Table United States Neuromodulation Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Neuromodulation by Type (2011-2016)

Table United States Neuromodulation Price by Type (2011-2016)

Figure United States Neuromodulation Sales Growth Rate by Type (2011-2016)

Table United States Neuromodulation Sales by Application (2011-2016)

Table United States Neuromodulation Sales Market Share by Application (2011-2016)

Figure United States Neuromodulation Sales Market Share by Application in 2015

Table United States Neuromodulation Sales Growth Rate by Application (2011-2016)

Figure United States Neuromodulation Sales Growth Rate by Application (2011-2016)

Table Medtronic, Inc. (U.S.) Basic Information List

Table Medtronic, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Medtronic, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table Boston Scientific Corporation (U.S.) Basic Information List

Table Boston Scientific Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boston Scientific Corporation (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table St. Jude Medical, Inc. (U.S.) Basic Information List

Table St. Jude Medical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table St. Jude Medical, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table Synapse Biomedical, Inc. (U.S.) Basic Information List

Table Synapse Biomedical, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Synapse Biomedical, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table Nevro Corporation (U.S.) Basic Information List

Table Nevro Corporation (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nevro Corporation (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table Neurosigma, Inc. (U.S.) Basic Information List

Table Neurosigma, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neurosigma, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table Neuropace, Inc. (U.S.). Basic Information List

Table Neuropace, Inc. (U.S.). Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neuropace, Inc. (U.S.). Neuromodulation Sales Market Share (2011-2016)

Table Neuronetics, Inc. (U.S.) Basic Information List

Table Neuronetics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neuronetics, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table Cyberonics, Inc. (U.S.) Basic Information List

Table Cyberonics, Inc. (U.S.) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cyberonics, Inc. (U.S.) Neuromodulation Sales Market Share (2011-2016)

Table BioControl Medical (Israel) Basic Information List

Table BioControl Medical (Israel) Neuromodulation Sales, Revenue, Price and Gross Margin (2011-2016)

Table BioControl Medical (Israel) Neuromodulation Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Neuromodulation

Figure Manufacturing Process Analysis of Neuromodulation

Figure Neuromodulation Industrial Chain Analysis

Table Raw Materials Sources of Neuromodulation Major Manufacturers in 2015

Table Major Buyers of Neuromodulation

Table Distributors/Traders List

Figure United States Neuromodulation Production and Growth Rate Forecast (2016-2021)

Figure United States Neuromodulation Revenue and Growth Rate Forecast (2016-2021)

Table United States Neuromodulation Production Forecast by Type (2016-2021)

Table United States Neuromodulation Consumption Forecast by Application (2016-2021)